D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FL
2726
CALL
DELISTED
Foot Locker
FL
| $2.37M | ﹤0.01% |
52,000
| – | – |
|
2727
Prothena Corp
PRTA
$448M
| $2.37M | ﹤0.01% |
33,321
+13,026
| +64% | +$809K |
|
2728
Iron Mountain
IRM
$35.9B
| $2.37M | ﹤0.01% |
+54,566
| New | +$2.46M |
|
2729
CALL
ArcelorMittal
MT
$49.5B
| $2.37M | ﹤0.01% |
78,500
| – | – |
|
|
GNAC
2730
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
| $2.37M | ﹤0.01% |
243,035
+16,294
| +7% | +$158K |
|
2731
Markel Group
MKL
$25.2B
| $2.37M | ﹤0.01% |
1,980
-2,153
| -52% | -$2.65M |
|
2732
Babcock & Wilcox
BW
$1.18B
| $2.36M | ﹤0.01% |
368,341
+296,315
| +411% | +$2.07M |
|
|
IRBT
2733
DELISTED
iRobot
IRBT
| $2.36M | ﹤0.01% |
30,054
+7,211
| +32% | +$614K |
|
2734
CALL
Louisiana-Pacific
LPX
$5.14B
| $2.36M | ﹤0.01% |
38,400
| – | – |
|
2735
PUT
Upbound Group
UPBD
$1.22B
| $2.34M | ﹤0.01% |
41,700
-41,300
| -50% | -$2.43M |
|
|
PSAG
2736
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
| $2.34M | ﹤0.01% |
241,619
+116,619
| +93% | +$1.12M |
|
2737
CALL
National Beverage
FIZZ
$3.06B
| $2.34M | ﹤0.01% |
44,600
| – | – |
|
2738
PUT
HealthEquity
HQY
$8.71B
| $2.34M | ﹤0.01% |
+36,100
| New | +$2.51M |
|
2739
Sonoco
SON
$5.83B
| $2.34M | ﹤0.01% |
39,238
+5,555
| +16% | +$355K |
|
2740
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
| $2.34M | ﹤0.01% |
37,840
| – | – |
|
|
GTH
2741
DELISTED
Genetron Holdings Limited ADS
GTH
| $2.34M | ﹤0.01% |
56,248
+6,064
| +12% | +$279K |
|
2742
Maximus
MMS
$3.32B
| $2.33M | ﹤0.01% |
28,019
+23,355
| +501% | +$2M |
|
2743
PUT
Inspire Medical Systems
INSP
$1.47B
| $2.33M | ﹤0.01% |
10,000
| – | – |
|
2744
PUT
Pultegroup
PHM
$25.2B
| $2.33M | ﹤0.01% |
50,700
+33,700
| +198% | +$1.75M |
|
2745
CALL
Bio-Techne
TECH
$11.2B
| $2.33M | ﹤0.01% |
19,200
-62,400
| -76% | -$7.59M |
|
2746
PDF Solutions
PDFS
$1.72B
| $2.33M | ﹤0.01% |
100,918
-59,554
| -37% | -$1.23M |
|
2747
PUT
GrowGeneration
GRWG
$84.7M
| $2.32M | ﹤0.01% |
94,200
+9,400
| +11% | +$332K |
|
2748
CALL
Newmont
NEM
$96.2B
| $2.32M | ﹤0.01% |
+42,700
| New | +$2.52M |
|
2749
Ecopetrol
EC
$33.7B
| $2.32M | ﹤0.01% |
161,514
-254,357
| -61% | -$3.45M |
|
2750
Lam Research
LRCX
$316B
| $2.31M | ﹤0.01% |
40,660
-94,840
| -70% | -$5.77M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.